
Bladder Cancer
Discover MPLN’s Bladder Cancer Kit using FISH technology for non-invasive, highly sensitive, & monitoring of bladder cancer.
Explore MPLN’s case studies and publications to gain insights into our innovative solutions and success stories and learn how we drive results.
Discover MPLN’s Bladder Cancer Kit using FISH technology for non-invasive, highly sensitive, & monitoring of bladder cancer.
For myelodysplastic syndromes, current therapy is selected based on risk, transfusion needs, percent of bone marrow blasts, cytogenetic and mutational profiles, comorbidities, potential for allogeneic
Explore MPLN’s cutting-edge multiplex immunohistochemistry for precise tissue analysis. Unravel complex microenvironments with our expert team and advanced technology.
Beyond informing drug target discovery, validation, and clinical development, it uncovers critical genetic markers that drive disease progression and influence individual treatment responses. This empowers healthcare professionals to create more precise, tailored treatment plans, optimizing medical management based on each patient’s genetic profile.
DNA Solutions – WGS*, WGMS*, WES*, TSO-500 Comp, Pillar OncoReveal
RNA Solutions – Total RNA-Seq*, RNA exome*, mRNA*
Liquid Biopsy Solutions – TSO-500 ctDNA, PGDx elio™ plasma complete*
*Offered through fully accredited partner laboratories.
Our advanced technology enables simultaneous visualization of single or multiple biomarkers within the same tissue section, delivering comprehensive insights and precise diagnostics. With unmatched expertise and cutting-edge technology, our team supports you in understanding complex tissue microenvironments, aiding patient stratification and treatment response prediction.